HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: OTC Rogaine

This article was originally published in The Rose Sheet

Executive Summary

OTC Rogaine: Will be available on store shelves in early April following FDA approval of the baldness remedy on Feb. 9. The company will offer both Rogaine for Men in blue packaging and Rogaine for Women in salmon-colored containers. Except for the packaging, the OTC formula, which includes 2% minoxidil, will be identical to prescription Rogaine. After failing to clear the proposed switch during its first review of Upjohn's application in July 1994, FDA's Nonprescription Drugs Advisory Committee recommended approval of the OTC switch at a subsequent meeting in November 1995 after seeing several new studies that tested consumer use and label comprehension ("The Rose Sheet" Nov. 27, p. 8)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002483

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel